The Decade of Vaccines Collaboration announced that it ended secretariat operations as of 31 December 2012, noting that “the work of the Decade of Vaccines is continuing – carried out by the stakeholders that developed the GVAP. The original plan was for the DoV Collaboration, including the secretariat, to dissolve or “sunset” at the end of 2012 so as not to create an additional structure. The countries, the regions and global health organizations will continue to carry out the vision of the GVAP at the country, regional and global levels.”
http://www.dovcollaboration.org/dov-collaboration-updates/december-2012-news-report/
The Weekly Epidemiological Record (WER) for 4 January 2013, vol. 88, 1 (pp 1–16) includes: Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 – conclusions and recommendations
http://www.who.int/entity/wer/2013/wer8801.pdf
[Editor’s Note: Below is an excerpt for the WER summary of the meeting’s GVAP agenda item]
Decade of Vaccines Global Vaccine Action Plan (GVAP)
“The session included an overview of progress in putting the GVAP into operation since the 65th World Health Assembly (WHA) in May 2012. Discussions have begun at the Regional level to update regional immunization plans in alignment with GVAP and to establish processes to monitor and report progress to the respective Regional Committees each year. The WHO and UNICEF guidance for preparation of national multi-year and annual plans for immunization are being updated to align them with the guiding principles and strategic objectives of GVAP and to foster greater alignment with national health sector plans.
‘The proposed structure and process for monitoring the implementation of the GVAP through a Monitoring & Evaluation /Accountability Framework was described. The framework has 3 elements: (i) monitoring results (based on the indicators for the GVAP Goals and Strategic Objectives); (ii) monitoring commitments and resources; and (iii) an independent review of progress.
Progress was described in the efforts to finalize monitoring indicators, establish operational definitions, sources of data, and the reporting process. SAGE was presented with the changes made to the indicators since its April 2012 meeting and the rationale for doing so, and was specifically asked for comments and recommendations.
“SAGE discussions mainly focused on:
(1) the feasibility and need for surveys to validate district level vaccine coverage measures; (2) adding an indicator of DTP3 coverage ≥80% for ≥3 years; (3) proposed indicators to measure “confidence in immunization”; (4) retention of indicator on district level DTP3 coverage; (5) choice of drop-out rate between the first dose of DTP and first dose of measles containing vaccine (MCV1) (DTP1-MCV1), or between the first and third dose of DTP vaccine (DTP1-DTP3); (6) addition of a surveillance indicator; (7) addition of an indicator to measure integration of immunization within health systems; and (8) addition of a vaccine price indicator…”
The WHO Executive Board will review an update to the GVAP at its 132nd session [EB132] in Geneva, 21–29 January 2013. The agenda item is listed as:
9. Communicable diseases
9.1 Global vaccine action plan
The supporting document – EB132/18 – is not yet posted.
vaccines and global health :: ethics and policy 